Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon α 2b, doxorubicin, and 5-fluorouracil : A communication
- Author
- PATT, Y. Z1 ; HOQUE, A1 ; ROH, M2 3 ; ELLIS, L2 ; LOZANO, R4 ; CARRASCO, C. H; CHARNSANGAVEJ, C5 ; CLEARY, K6
[1] Department of Gastrointestinal Medical Oncology and Digestive Diseases, Division of Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
[2] Department of Surgical Oncology, Division of Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
[3] Department of Surgical Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
[4] Division of Pharmacy, Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
[5] Department of Diagnostic Radiology. Division of Diagnostic Imaging, Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
[6] Department of Pathology, Division of Pathology, Allegheny General Hospital, Pittsburgh, Pennsylvania, United States - Source
American journal of clinical oncology. 1999, Vol 22, Num 2, pp 209-213 ; ref : 32 ref
- CODEN
- AJCODI
- ISSN
- 0277-3732
- Scientific domain
- Medical oncology
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anthracyclines Anticancéreux Carcinome hépatocellulaire Cisplatine Doxorubicine Efficacité traitement Etude cas Fluoropyrimidine dérivé Fluorouracil Homme Immunochimiothérapie Interféron alpha Platine II Complexe Pyrimidine dérivé Tissu tumoral Traitement Voie intraartérielle Voie intrahépatique Appareil digestif pathologie Cytokine Foie pathologie Tumeur maligne
- Keyword (en)
- Anthracyclins Antineoplastic agent Hepatocellular carcinoma Cisplatin Doxorubicin Treatment efficiency Case study Fluoropyrimidine derivatives Fluorouracil Human Immunochemotherapy Alpha interferon Platinum II Complexes Pyrimidine derivatives Tumoral tissue Treatment Intraarterial administration Intrahepatic administration Digestive diseases Cytokine Hepatic disease Malignant tumor
- Keyword (es)
- Antraciclinas Anticanceroso Carcinoma hepatocelular Cisplatino Doxorubicina Eficacia tratamiento Estudio caso Fluoropirimidina derivado Fluorouracilo Hombre Inmunoquimioterapia Interferón alfa Platino II Complejo Pirimidina derivado Tejido tumoral Tratamiento Vía intraarterial Vía intrahepática Aparato digestivo patología Citoquina Hígado patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 1729464
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1097/00000421-199904000-00024 
https://dx.doi.org/10.1097/00000421-199904000-00024
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1097\/00000421-199904000-00024\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:209:\"Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon \u03b1 2b, doxorubicin, and 5-fluorouracil : A communication\";s:9:\"\u0000*\u0000jtitle\";s:37:\"American journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:18:\"Am. j. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"22\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"209\";s:8:\"\u0000*\u0000epage\";s:3:\"213\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-3732\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"PATT\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Y. Z\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:8:\"HOQUE, A\";i:1;s:6:\"ROH, M\";i:2;s:8:\"ELLIS, L\";i:3;s:9:\"LOZANO, R\";i:4;s:14:\"CARRASCO, C. H\";i:5;s:16:\"CHARNSANGAVEJ, C\";i:6;s:9:\"CLEARY, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJCODI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:209:\"Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon \u03b1 2b, doxorubicin, and 5-fluorouracil : A communication\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1097\/00000421-199904000-00024\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:209:\"Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon \u03b1 2b, doxorubicin, and 5-fluorouracil : A communication\";s:9:\"\u0000*\u0000jtitle\";s:37:\"American journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:18:\"Am. j. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"22\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"209\";s:8:\"\u0000*\u0000epage\";s:3:\"213\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-3732\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"PATT\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Y. Z\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:8:\"HOQUE, A\";i:1;s:6:\"ROH, M\";i:2;s:8:\"ELLIS, L\";i:3;s:9:\"LOZANO, R\";i:4;s:14:\"CARRASCO, C. H\";i:5;s:16:\"CHARNSANGAVEJ, C\";i:6;s:9:\"CLEARY, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJCODI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:209:\"Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon \u03b1 2b, doxorubicin, and 5-fluorouracil : A communication\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1097\/00000421-199904000-00024\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1097\/00000421-199904000-00024\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:209:\"Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon \u03b1 2b, doxorubicin, and 5-fluorouracil : A communication\";s:9:\"\u0000*\u0000jtitle\";s:37:\"American journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:18:\"Am. j. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"22\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"209\";s:8:\"\u0000*\u0000epage\";s:3:\"213\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-3732\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"PATT\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Y. Z\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:8:\"HOQUE, A\";i:1;s:6:\"ROH, M\";i:2;s:8:\"ELLIS, L\";i:3;s:9:\"LOZANO, R\";i:4;s:14:\"CARRASCO, C. H\";i:5;s:16:\"CHARNSANGAVEJ, C\";i:6;s:9:\"CLEARY, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJCODI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:209:\"Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon \u03b1 2b, doxorubicin, and 5-fluorouracil : A communication\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1097\/00000421-199904000-00024\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:209:\"Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon \u03b1 2b, doxorubicin, and 5-fluorouracil : A communication\";s:9:\"\u0000*\u0000jtitle\";s:37:\"American journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:18:\"Am. j. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"22\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"209\";s:8:\"\u0000*\u0000epage\";s:3:\"213\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-3732\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"PATT\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Y. Z\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:8:\"HOQUE, A\";i:1;s:6:\"ROH, M\";i:2;s:8:\"ELLIS, L\";i:3;s:9:\"LOZANO, R\";i:4;s:14:\"CARRASCO, C. H\";i:5;s:16:\"CHARNSANGAVEJ, C\";i:6;s:9:\"CLEARY, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJCODI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:209:\"Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon \u03b1 2b, doxorubicin, and 5-fluorouracil : A communication\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1097\/00000421-199904000-00024\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:209:\"Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon \u03b1 2b, doxorubicin, and 5-fluorouracil : A communication\";s:9:\"\u0000*\u0000jtitle\";s:37:\"American journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:18:\"Am. j. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"22\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"209\";s:8:\"\u0000*\u0000epage\";s:3:\"213\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-3732\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"PATT\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Y. Z\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:8:\"HOQUE, A\";i:1;s:6:\"ROH, M\";i:2;s:8:\"ELLIS, L\";i:3;s:9:\"LOZANO, R\";i:4;s:14:\"CARRASCO, C. H\";i:5;s:16:\"CHARNSANGAVEJ, C\";i:6;s:9:\"CLEARY, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJCODI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:209:\"Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon \u03b1 2b, doxorubicin, and 5-fluorouracil : A communication\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
